Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity

Differentiation

Volumn 62, Issue 4, 1998, Pages 203-211

  Kataoka, Hiroshi ^a   Tahara, Hidetoshi ^b   Watanabe, Taro ^b   Sugawara, Minoru ^a   Ide, Toshinori ^b   Goto, Makoto ^c   Furuichi, Yasuhiro ^a   Sugimoto, Masanobu ^a  

^a AGENE Research Institute   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c Tokyo Metropolitan Ohtsuka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; IMMUNOGLOBULIN M; TELOMERASE;

ARTICLE; B LYMPHOBLAST; CELL IMMORTALIZATION; CELL POPULATION; CELL PROLIFERATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; KARYOTYPE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

HUMAN HERPESVIRUS 4;

EID: 0031427332     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.1998.6240203.x     Document Type: Article

References (23)

1. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bachetti S, Greider CW (1996) Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650
2. Broccoli D, Young J, De Lange T (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92:9082-9086
3. Brown N, Liu C, Berenson JR, Garcia CR, Wang R, Calame KL (1985) Immunoglobulin JH, Cu, and Cλ gene rearrangements in human B lymphocytes clonally transformed by Epstein-Barr virus. Proc Natl Acad Sci USA 82:556-560
4. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240-4248
5. Chan MA, Stein LD, Dosch H-M, Sigal NH (1986) Heterogeneity of EBV-transformable human B lymphocyte populations. J Immunol 136:106-112
6. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S (1994) Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68:3410-3414
7. Epstein CJ, Martin GM, Schultz AL, Motulsky AG (1966) Werner's syndrome: A review of its symptomatology, natural history, pathologic factors, genetics and relationship to the natural aging process. Medicine 45:177-221
8. Freshney RI (1987) A manual of basic technique. In: Culture of animal cells, 2nd ed. Alan R Liss Inc. New York, pp 175-179
9. Goto M, Miller RW, Ishikawa Y, Sugano H (1996) Excess of rare cancers in Werner syndrome (adult progeria). Can Epi Bio Prev 5:239-246
10. Goto M, Rubenstein M, Weber J, Woods K, Drayna D (1992) Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature 355:735-738
11. Goto M, Tanimoto K, Aotsuka S, Okawa M, Horiuchi Y (1982) Age-related changes in auto- and natural antibody in the Werner's syndrome. Am J Med 72:607-614
12. Goto M, Tanimoto K, Horiuchi Y, Sasazuki T (1981) Family analysis of Werner's syndrome: a survey of 42 Japanese families with a review of the literature. Clin Genet 19:8-15
13. Gregory CD, Kirchgens C, Edwards CF, Young LS, Rowe M, Forster A, Rabbits TH, Rickinson AB (1987) Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with gremlin or rearranged but nonexpressed heavy chain genes. Eur J Immunol 17:1199-1207
14. James K, Bell GT (1987) Human monoclonal antibody production. Current status and future prospects. J Immunol Meth 100:5-40
15. Kehrl JH, Riva A, Wilson GL, Thevenin C (1994) Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol Today 15:432-436
16. Kim NW, Piatyszek MA, Prowse KR, Harley CJW, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
17. Matsumoto T, Imamura O, Yamabe Y, Kuromitsu J, Tokutake Y, Shimamoto A, Suzuki N, Satoh M, Kitao S, Ichikawa K, Kataoka H, Sugawara K, Thomas W, Mason B, Tsuchihashi Z, Drayna D, Sugawara M, Sugimoto M, Furuichi Y, Goto M (1997) Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure: genetic edpidemiology in the Japanese population. Hum Genet 100:123-130
18. Miller G (1990) Epstein-Barr virus biology, pathogenesis and medical aspects. In: Fields BN, Knipe KM (eds) Virology. Raven Press, New York, pp 1921-1958
19. Norrback KF, Dahlenborg K, Carlsson R, Roos G (1996) Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88:222-229
20. Roder JC, Cole SPC, Kozbor D (1986) [12] The EBV-hybridoma technique. Meth Enzymol 121:140-167
21. Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, Satoh M, Matsumoto T, Sugawara M, Ide T, Goto M, Furuichi Y, Sugimoto M (1997) Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15:1911-1920
22. Tosato G, Blaese RM, Yarchoan R (1985) Relationship between immunoglobulin production and immortalization by Epstein Barr virus. J Immunol 135:959-964
23. Wright WE, Shay JW, Piatyszek MA (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acis Res 23:3794-3495